[1]
Jonathan, A. et al. 2020. Decreased in Liver Fibrosis in Patients with HCV/HIV Coinfection After Treatment with Sofosbuvir/Daclatasvir. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 20, 2 (July 2020), 87–95. DOI:https://doi.org/10.24871/202201987-95.